Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness.AuthorsCanepa, Elisa; Parodi‐Rullan, Rebecca; Vazquez‐Torres, Rafael; Gamallo‐Lana, Begona; Guzman‐Hernandez, Roberto; Lemon, Nicole L.; Angiulli, Federica; Debure, Ludovic; Ilies, Marc A.; Østergaard, Leif; Wisniewski, Thomas; Gutiérrez‐Jiménez, Eugenio; Mar, Adam C.; Fossati, SilviaPublicationAlzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, Vol 19, Issue 11, p5048ISSN1552-5260Publication typeArticleDOI10.1002/alz.13063